维普期刊资源整合服务平台（V6.5）

245篇 您的检索式：作者名="Bookman"

选中清除导出查看参考文献查看引证文献引用追踪共13页首页上一页第1页下一页末页 /13 跳转

	题名	作者	年代	出处	被引量
1	Evaluation of monoclonal humanized anti-HER2 antibody,trastuzumab,in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2:a phase II trial of the Gynecologic Oncology Group显示文摘	Bookman MA Darcy KM Clarke-Pearson D	2003	J Clin Oncol2003，21，2：	1
2	Topotecon for the treatment of advanced epithelial ovarian cancer:an popenlabel phase Ⅱ study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel显示文摘	BOOKMAN M A MALMSTORM L H BOLSG	1998	Clin Oncol1998，16，10：	1
3	Reporting genetic results in research studies: summary and recommendations of an NHLBI working group 显示文摘	Bookman EB Langehome AA Eekfeldt JH	2006	Am J Med Genet A2006，140，10：	1
4	Incorporation of bevacizumab in the primary treatment of ovarian cancer 显示文摘	Burger RA Brady MF Bookman MA	2011	N Engl JMed2011，365，26：	1
5	Wind energy' s promise, offshore 显示文摘	Bookman T	2005	IEEE Technology and Society Magazine2005，24，2：	1
6	Second-line treatment of ovarian cancer显示文摘	Markman M Bookman M A	2000	Oncologist2000，5，1：	1
7	Gemcitabine monotherapy in recurrent ovarian cancer:from the bench to the clinic显示文摘	Bookman MA	2005	Int J Gynecol Cancer2005，15，1：	1
8	Focus on epithelial ovarian cancer 显示文摘	Ozols RF Bookman MA Cormolly DC	2004	Cancer Cell2004，5，1：	1
9	Carboplatin and paclitaxel in ovarian carcinoma: a phase Ⅰ study of the Gynecologic Oncology Group 显示文摘	Bookman MA McGuire WP Ⅲ Kilpatrick D	1996	J Clin Oncol1996，14，：	1
10	Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer:a Phase III Trial of the Gynecologic Cancer Intergroup显示文摘	Bookman MA Brady MF McGuire WP		0，，：	1
11	Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers显示文摘	Edge SB Niland JC Bookman MA	2003	J Nail Cancer Inst2003，95，20：	1
12	Developmental chemotherapy in advanced ovarian cancer:incorporation of newer cytotoxic agents in a phase Ⅲ randomized trial of the Gynecologic Ocology Group(GOG 0182)显示文摘	Bookman MA	2002	Semin Oncol2002，29，4：	1
13	The bimodal mortality pattern of systemic lupus erythematosus显示文摘	Urowitz MB Bookman AA Koehler BE	1976	Am J Med1976，60，2：	1
14	The bi- modal mortality pattern of systemic lupus erythematosus 显示文摘	Urowitz M B Bookman A A Koehler B E	1976	Am J Med1976，60，2：	1
15	健康教育的'KAP'模型及设计(二)显示文摘	Bookman D	2009	华西预防医学2009，17，1：	1
16	The bimodal mortality pattern of systemic lupus erythematosus 显示文摘	Urowitz MB Bookman AA Koehler BE	1976	Am J Med1976，60，2：	1
17	Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: a GOG study 显示文摘	McGuire WP Blessing JA Bookman MA	2000	J Clin Oncol2000，18，5：	1
18	Incorporation of bevacizumab in the primary treatment of ovarian cancer显示文摘	Burger RA Brady MF Bookman MA	2011	New Engl J Med2011，365，26：	1
19	Necrotizing glomerulonephritis caused by Bartonella henselae endocarditis显示文摘	Bookman I Scholey JW Jassal SV	2004	Am J Kidney Dis2004，43，2：	1
20	A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors 显示文摘	Posey JA Khazaeli MB Bookman MA	2002	Clin Cancer Res2002，8，10：	1

返回顶部每页显示：

共13页首页上一页第1页下一页末页 /13 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示